Population
18 cases of laryngeal angiosarcoma
Design
Systematic_review
Follow-up
mean 34.1 months
Authors
Loading...
Alerts clinicians to high disseminated mortality risk in laryngeal angiosarcoma; extends sparse evidence and supports systemic therapy trials.
Laryngeal angiosarcoma is a rare disease with poor prognosis where 47% of patients die of disseminated disease, though serial resection may be beneficial in some cases.
Qualls et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: